Syndrome des antiphospholipides
Veille bibliographique : Syndrome des antiphospholipides
Les articles sont classés du plus ancien au plus récent, n’hésitez pas à utiliser la barre de recherche pour filtrer les résultats par date par exemple.
| Saccone G et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017 Jan 30 | Lire le résumé |
| Cochery-Nouvellon É et al. Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. The NOH-ANGIO observational cohort study. Haematologica. 2017 Jan 25 | Lire le résumé |
| Abrahams VM et al. The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome. J Hum Genet. 2017 Apr 20 | Lire le résumé |
| Mimi Kim et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Ann Rheum Dis published on January 25, 2018 | Lire le résumé |
| Rashidi A, Fisher SI. Clinical Images: Lupus erythematosus cell. Arthritis & Rheumatology. 2018 May 14 Nakamura H, Fujieda Y, Yasuda S, Nakai M, Atsumi T. Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus. Ann Intern Med. 2018 May 1; Sciascia Sciascia SS, Rubini E, Radin M, Cecchi I, Rossi D, Roccatello D. Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. Annals of the Rheumatic Diseases. 2018 May 18; annrheumdis-2018-213496. | Lire le résumé |
| Pengo V, Denas G, Zoppellaro G, Padayattil Jose S, Hoxha A, Ruffatti A, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018 Jul 12;blood-2018-04-848333. | Lire le résumé |
| Sanchez A, Montaudie H, Bory P, Belgodere X, Passeron T, Lacour JP, et al. Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma. JAMA Dermatology [Internet]. 2018 Sep 19 [cited 2018 Oct 23]; | Lire le résumé |
| Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The Epidemiology of Antiphospholipid Syndrome. A Population‐Based Study. Arthritis Rheumatol [Internet]. 8 avr 2019 [cité 23 avr 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40901 | Lire le résumé |
| Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The Epidemiology of Antiphospholipid Syndrome. A Population‐Based Study. Arthritis Rheumatol [Internet]. 8 avr 2019 [cité 23 avr 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40901 | Lire le résumé |
| Gris J-C, Mousty È, Bouvier S, Ripart S, Cochery-Nouvellon É, Fabbro-Peray P, et al. Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the the NOH-APS cohort., Haematologica. 17 mai 2019;haematol.2018.213991 | Lire le résumé |
| Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmun Rev. avr 2019;18(4):406‑14 | Lire le résumé |
| Jesús G, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, et al. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome ( APS ) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG Int J Obstet Gynaecol [Internet]. 24 oct 2018 [cité 14 mai 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.15469 | Lire le résumé |
| Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri J-L, Guerra MM, et al. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome. Lupus. sept 2018;27(10):1679 86 | Lire le résumé |
| Ordi-Ros J, Sáez-Comet L, Pérez-Conesa M, Vidal X, Riera-Mestre A, Castro-Salomó A, et al. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial. Ann Intern Med [Internet]. 15 oct 2019 [cité 23 oct 2019]; | Lire le résumé |
| Chatzidionysiou K, Samoli E, Sfikakis PP, Tektonidou MG. Effect of belimumab treatment on antiphospholipid antibodies levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus. Ann Rheum Dis. 11 nov 2019;annrheumdis-2019-216367 | Lire le résumé |
| Lockshin MD, Guerra M, Salmon JE. Elective termination of pregnancy in autoimmune rheumatic diseases. Arthritis Rheumatol [Internet]. 12 mars 2020 [cité 26 mars 2020]; | Lire le résumé |
| You Y, Shi C, Zhou Z, Wang F, Sun Y, Teng J, et al. Rituximab in thrombotic primary antiphospholipid syndrome: a pilot study from a single centre in China. Ann Rheum Dis. 15 janv 2021;annrheumdis-2020-219303. | Lire le résumé |
| Ruffatti A, Tonello M, Macor P, Calligaro A, Del Ross T, Favaro M, et al. Markers of complement activation in plasma during quiescent phases in catastrophic antiphospholipid syndrome patients. Blood [Internet]. 1 mars 2021 [cité 23 mars 2021]; | Lire le résumé |
| Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. oct 2023;82(10):1258‑70. | Lire le résumé |